Apollo Hospitals Enterprise Limited Latest Updates

Strong Q4 FY26 Financial Metrics Apollo Hospitals Enterprise Limited delivered solid growth for the fourth quarter ended March 31, 2026. Consolidated revenue from operations increased by 18.12% year-on-year to reach ₹6,606 crore, up from ₹5,592 crore in Q4 FY25. Consolidated net profit (PAT) surged 35.60% year-on-year to hit ₹529 crore compared to ₹390 crore in the corresponding quarter of the previous fiscal. Strategic Maternity and Fertility Care Combo Deal In a major corporate combination, Apollo Health and Lifestyle Limited (AHLL) signed a deal to merge its standalone Mother & Child and Fertility business verticals—operated under "Apollo Cradle" and "Apollo Fertility"—with Kids Clinic India Limited's "Cloudnine" brand. The transaction values AHLL's combined verticals at ₹1,550 crore. Post-transaction, Apollo will hold a 9.9% equity stake as the largest non-financial shareholder, along with board nominee representation. Core Subsidiary Merger Approved The Board of Directors gave the green light to a composite scheme of arrangement involving the formal merger of its wholly-owned subsidiary, Apollo Hospitals North Limited, directly into the primary holding company, Apollo Hospitals Enterprise Limited. The structural move is pending final statutory and regulatory clearances to streamline intra-group assets. Top-Tier Independent Director Re-appointment Based on the recommendations of the Nomination and Remuneration Committee, the board approved the re-appointment of Ms. Rama Bijapurkar as an Independent Director for a second consecutive five-year tenure. The new block will span from November 12, 2026, to November 11, 2031, subject to a special resolution vote from shareholders.